Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 44

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Association between biofilm and multi/extensive drug resistance in diabetic foot infection

Vatan, Aslı, Saltoglu, Nese, Yemisen, Mucahit, Balkan, Ilker Inanc, Surme, Serkan, Demiray, Tayfur, Mete, Birgul, Tabak, Fehmi, Study Group, Cerrahpasa Diabetic Foot · 2018 · International Journal of Clinical Practice

Abstract

PURPOSE: We aimed to determine significant risk factors for biofilm production and to investigate the association between antimicrobial resistance profile and biofilm formation in the bacterial isolates obtained from patients with diabetic foot infection (DFI). METHODS: Demographic, clinical, laboratory and outcome data of 165 patients, prospectively recorded and followed between January 2008 and December 2015 by a multidisciplinary committee, were analysed. Standard microbiological methods were adopted. Risk factors associated with biofilm were determined by univariate and multivariate analyses. RESULTS: The overall rate of biofilm production among 339 wound isolates was 34%. The biofilm production rate was significantly higher in Gram-negative micro-organisms (39%) in comparison with Gram positives (21%) (P = .01). A. baumannii presented the highest biofilm production (62%), followed by P. aeruginosa (52%) and Klebsiella spp. (40%). On univariate analysis, significant factors associated with biofilm were antibiotic use within last 3 months (OR:2.94, CI: 1.5-5.75, P = .002), recurrent DFI within last 6 months (OR:2.35, CI: 1.23-4.53, P = .01), hospitalisation within last 3 months due to ipsilateral recurrent DFI (OR:2.44, CI: 1.06-5.58, P = .03), presence of amputation history (OR: 2.20, CI: 1.14-4.24, P = .01), multidrug-resistant (MDR) micro-organism (OR: 7.76, CI: 4.53-13.35, P<.001) and extensively drug-resistant (XDR) micro-organism (OR:11.33, CI:4.97-26.55, P<.001). Multivariate regression analysis revealed two variables to be significant factors associated with biofilm: MDR micro-organism (OR: 3.63, CI: 1.58-8.33, P = .002) and XDR micro-organism (OR:4.06, CI: 1.25-13.1, P = .01). CONCLUSIONS: Multi/extensive drug resistance and previous recurrent DFIs were significantly associated with biofilm formation in patients with diabetic foot.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ijcp.13060

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 35

  1. Lipsky, 2016, Diabetic foot infections: current treatment and delaying the ‘post-antibiotic era’, Diabetes Metab Res Rev, 32, 246, 10.1002/dmrr.2739 · doi:10.1002/dmrr.2739
  2. Saltoglu, 2015, Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey, Clin Microbiol Infect, 21, 659, 10.1016/j.cmi.2015.03.018 · DOI
  3. Høiby, 2010, Antibiotic resistance of bacterial biofilm, Int J Antimicrob Agents, 35, 322, 10.1016/j.ijantimicag.2009.12.011 · DOI · Paper page
  4. Percival, 2004, Biofilms and their potential role in wound healing, Wounds, 16, 234
  5. Malone, 2017, Approaches to biofilm-associated infections: the need for standardized and relevant biofilm methods for clinical applications, Expert Rev Anti Infect Ther, 15, 147, 10.1080/14787210.2017.1262257 · DOI
  6. Percival, 2015, Biofilms and wounds: an overview of the evidence, Advances in Wound Care, 4, 373, 10.1089/wound.2014.0557 · DOI · Paper page
  7. Mottola, 2016, Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections, BMC Microbiol, 16, 119, 10.1186/s12866-016-0737-0 · DOI · Paper page
  8. Donlan, 2002, Biofilms: survival mechanisms of clinically relevant microorganisms, Clin Microbiol Rev, 15, 167, 10.1128/CMR.15.2.167-193.2002 · DOI · Paper page
  9. Høiby, 2015, ESCMID guideline for the diagnosis and treatment of biofilm infections 2014, Clin Microbiol Infect, 21, S1, 10.1016/j.cmi.2014.10.024 · DOI · Paper page
  10. Gadepalli, 2006, Clinico microbiological study of diabetic foot ulcers in an Indian tertiary care hospital, Diabetes Care, 29, 1727, 10.2337/dc06-0116 · doi:10.2337/dc06-0116
  11. Ramakant, 2011, Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?, Diabetologia, 54, 58, 10.1007/s00125-010-1893-7 · doi:10.1007/s00125-010-1893-7
  12. Shashikala, 2016, Diabetic foot ulcers and biofilm formation, Intern J Biomed and Advance Res, 7, 428, 10.7439/ijbar.v7i9.3594 · DOI
  13. Murali, 2014, Characteristics of microbial drug resistance and its correlates in chronic diabetic foot ulcer infections, J Med Microbiol, 63, 1377, 10.1099/jmm.0.076034-0 · DOI
  14. Mah, 2001, Mechanisms of biofilm resistance to antimicrobial agents, Trends Microbiol, 9, 34, 10.1016/S0966-842X(00)01913-2 · DOI · Paper page
  15. Davis, 2006, The diabetic foot: the importance of biofilms and wound bed preparation, Curr Diab Rep, 6, 439, 10.1007/s11892-006-0076-x · DOI
  16. Lipsky, 2012, 2012 Infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections, Clin Infect Dis, 54, 132, 10.1093/cid/cis346 · DOI · Paper page
  17. Schaper, 2004, Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies, Diabetes Metab Res Rev, 20, S90, 10.1002/dmrr.464 · DOI · Paper page
  18. Stepanovic, 2000, A modified microtiter-plate test for quantification of staphylococcal biofilm formation, J Microbiol Methods, 40, 175, 10.1016/S0167-7012(00)00122-6 · DOI · Paper page
  19. Bianchi, 2016, Recommendations for the management of biofilm: a consensus document, J Wound Care, 25, 305, 10.12968/jowc.2016.25.6.305 · DOI
  20. Johani, 2017, Microscopy visualisation confirms multi-species biofilms are ubiquitous in diabetic foot ulcers, Int Wound J, 14, 1160, 10.1111/iwj.12777 · DOI · Paper page
  21. Malik, 2013, The diabetic foot infections: biofilms and antimicrobial resistance, Diabetes Metab Syndr, 7, 101, 10.1016/j.dsx.2013.02.006 · DOI
  22. Banu, 2015, Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: a prospective study, Australas Med J, 8, 280, 10.4066/AMJ.2015.2422 · DOI
  23. Mottola, 2016, Polymicrobial biofilms by diabetic foot clinical isolates, Folia Microbiol (Praha), 61, 35, 10.1007/s12223-015-0401-3 · DOI · Paper page
  24. Bjarnsholt, 2013, The role of bacterial biofilms in chronic infections, APMIS Suppl, 136, 1, 10.1111/apm.12099 · DOI · Paper page
  25. Sanchez, 2013, Biofilm formation by clinical isolates and the implications in chronic infections, BMC Infect Dis, 13, 2, 10.1186/1471-2334-13-47 · DOI · Paper page
  26. Rao, 2008, Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii, Indian J Med Microbiol, 26, 333, 10.4103/0255-0857.43566 · doi:10.4103/0255-0857.43566
  27. Tomaras, 2003, Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system, Microbiol, 149, 3473, 10.1099/mic.0.26541-0 · DOI · Paper page
  28. Zubair, 2011, A study of biofilm production by gram-negative organisms isolated from diabetic foot ulcer patients, Biol Med, 3, 147
  29. Vital-Lopez, 2015, Biofilm formation mechanisms of Pseudomonas aeruginosa predicted via Genome-Scale kinetic models of bacterial metabolism, PLoS Comput Biol, 11, e1004452, 10.1371/journal.pcbi.1004452 · DOI
  30. Colvin, 2012, The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix, Environ Microbiol, 14, 1913, 10.1111/j.1462-2920.2011.02657.x · DOI · Paper page
  31. Percival, 2010, Microbiology of Wounds, 293, 10.1201/9781420079944-c11 · DOI
  32. Percival, 2012, A review of the scientific evidence for biofilms in wounds, Wound Repair Regen, 20, 647, 10.1111/j.1524-475X.2012.00836.x · DOI · Paper page
  33. Trivedi, 2014, Prevalence of multiple antibiotic resistant infections in diabetic versus nondiabetic wounds, J Pathog, 2014, 173053, 10.1155/2014/173053 · DOI
  34. Zubair, 2010, Clinico-bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in north India, Biology and Medicine, 2, 22
  35. Espinal, 2012, Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces, J Hosp Infect, 80, 56, 10.1016/j.jhin.2011.08.013 · DOI · Paper page

Cited by

Metadata

Authors
Vatan, A., Saltoglu, N., Yemisen, M., Balkan, I. I., Surme, S., Demiray, T., Mete, B., Tabak, F., & Study Group, C. D. F.
Affiliations
  • Cerrahpasa Medical Faculty; Infectious Diseases and Clinical Microbiology; Istanbul University; Istanbul Turkey
  • Sakarya University Medical Faculty; Microbiology; Sakarya Turkey
Venue
International Journal of Clinical Practice
Publisher
Wiley
Published
2018-01-30
Volume
72
Issue
3
Pages
e13060
ISSN
1368-5031
Cited by
44
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.